ANTISEDAN DIN 02237744
Status: Marketed
Holder: ORION CORPORATION
Health Canada record
| Active ingredient(s) | ATIPAMEZOLE HYDROCHLORIDE 5 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intramuscular |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 01-Aug-2000 |
|---|
| Current status date | 24-Mar-2011 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Orion Oyj / Orion Corporation / Orion Pharma — licence , not currently licensed, last inspection rating C (2024-11-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ATIPAMEZOLE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02490900 | ATAJECT | GREY WOLF ANIMAL HEALTH INC | Solution | ATIPAMEZOLE HYDROCHLORIDE 5 MG | Marketed |
| 02491710 | ATIPAM | EUROVET ANIMAL HEALTH B.V. | Solution | ATIPAMEZOLE HYDROCHLORIDE 5 MG | Marketed |
| 02337207 | REVERTOR | MODERN VETERINARY THERAPEUTICS LLC | Solution | ATIPAMEZOLE HYDROCHLORIDE 5 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 12209 | 2011-03-23 | Supplement to a New Drug Submission (SNDS) | |
| 6567 | 1998-04-15 | New Drug Submission (NDS) | |
Request a quote for ANTISEDAN
How to read a Canadian DIN record